15 June 2022 - This marks the first TGA approval for Jazz Pharmaceuticals. ...
15 June 2022 - Tebentafusp is a bi-specific fusion protein. ...
8 June 2022 - Kimmtrak demonstrated statistically and clinically meaningful overall survival benefit, hazard ratio of 0.51, with median overall survival ...
26 May 2022 - The TGA has updated its list of applications for new medicines or new uses for existing ...
26 May 2022 - Osilodrostat phosphate is a cortisol synthesis inhibitor. ...
17 May 2022 - After agreeing to settle with Amgen over its oncology biosimilars, Pfizer issued a new patent lawsuit ...
6 May 2022 - On 7 April 2022, the TGA announced receipt of an application from GSK for a higher (1000 ...
19 April 2022 - The TGA has updated its list of applications for new medicines or new uses for existing medicines ...
13 April 2022 - Sotorasib is a Kirsten rat sarcoma (KRAS) G12C inhibitor, which covalently and irreversibly binds to the unique ...
12 April 2022 - Anifrolumab is a human immunoglobulin G1 kappa monoclonal antibody that binds to subunit 1 of the type ...
8 April 2022 - The TGA has approved yet another adalimumab biosimilar. ...
7 April 2022 - The TGA has received an application from GSK for a higher (1,000 mg) dose of its ...
7 April 2022 - Bimekizumab is a humanised immunoglobulin G1 kappa monoclonal antibody. It has two identical antigen binding regions that ...
4 April 2022 - The Morrison Government is supporting new local jobs in Australia’s innovative medical sector and investing to secure ...
4 April 2022 - The TGA has approved Vumerity (diroximel fumarate). ...